Meihua Holdings Group Co., Ltd. (SHSE:600873) entered into a framework agreement to acquire Dalian Hissen Biopharm Co. from Tibet Yiyuan Industry Co., Ltd. for approximately CNY 600 million on December 31, 2013. As of December 31, 2012, Dalian Hissen BioPharm Co., Ltd. has total assets of CNY 295.01 million and net assets of CNY 167.31 million. The transaction has been approved by Board of Directors of Meihua Holdings on December 31, 2013.

Meihua Holdings Group Co., Ltd. signed an agreement to acquire Dalian Hissen Biopharm Co. from Tibet Yiyuan Industry Co., Ltd. on June 16, 2014. Meihua Holdings Group Co., Ltd. paid CNY 400 million and will pay remaining CNY 200 million upon the fulfillment of all the provisions in the agreement. Meihua Holdings Group Co., Ltd. will operate Dalian Hissen Biopharm Co. as its wholly owned subsidiary.